Document is current
Any future updates will be listed below
-
Authors
Kaluba, Faith C.
Rogers, Thomas J.
Jeong, Yu-Jin
House, Rachel ‘Rae’ J. https://orcid.org/0000-0003-2176-0431
Waldhart, Althea
Sokol, Kelly H.
Daniels, Samuel R.
Lee, Cameron J.
Longo, Joseph https://orcid.org/0000-0002-9580-5105
Johnson, Amy
Sartori, Vincent J. https://orcid.org/0000-0001-6591-029X
Sheldon, Ryan D. https://orcid.org/0000-0002-1573-9719
Jones, Russell G. https://orcid.org/0000-0003-2250-4675
Lien, Evan C. https://orcid.org/0000-0001-7866-4761
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R00CA255928, 5T32CA251066-03)
Van Andel Institute Pathway-to-Independence Postdoctoral Award
Gouvernement du Canada | Canadian Institutes of Health Research (MFE-181903)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI165722)
- License Information
-
More Information
Article History
Received: 11 February 2025
Accepted: 6 August 2025
First Online: 8 September 2025
Competing interests
: R.G.J. is a scientific advisor to Servier Pharmaceuticals and is a member of the Scientific Advisory Board of Immunomet Therapeutics. The other authors declare no competing interests.
